Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Protect Your Practice: Action Update From the ACR’s Insurance Subcommittee

Carina Stanton  |  November 5, 2018

Right now, the ISC is working toward a similar goal with UnitedHealthcare (UHC) and Medicare, and is waiting to see if Medicare’s final rule will include removing its proposed modifier payment reduction policy. Regarding UHC’s position, after some advocacy efforts made by the ISC and others, UHC has put on hold a decision regarding modifier 25 payment reduction policies, saying it will wait to see what Medicare decides and will then reevaluate, Dr. Phillips shares.

Site-of-Service Restrictions for Infused Biologics
Over the past several years, the ACR has engaged with 10 different health plans regarding policies that limit the site of service for patients receiving infusions. The payers implementing these policies have the stated goal of moving infusions from hospital outpatient facilities to other, less costly settings. The policies permit patients to receive their infusions at home, in a physician’s office or in another non-hospital-based infusion center. Most grant exceptions for initiating or reinitiating therapy, as well as for patients with a history of severe infusion reactions or other medical risks or comorbidities.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“We have firsthand accounts from members who have shared cases where patient harm occurred due to these policies and decreased access,” Dr. Phillips says. The ACR’s position is to advocate for safe administration of infused biologics in a monitored healthcare setting with on-site supervision by a provider with appropriate training in biologic infusions; the ISC continues to successfully dialogue with payers for this.

Downcoding Administration of Certain Biologics by UHC
Following continued advocacy from the ISC and other physician and patient stakeholders, UHC announced on Nov. 1 that a policy to downcode reimbursement for administration of four drugs is “undergoing additional evaluation” and will not be implemented on Dec. 1 as planned. No future effective date has been announced. This policy would have ended reimbursement of the complex administration codes (96413 and 96415) for four drugs—Actemra, Entyvio, Orencia and Simponi—instead requiring providers to use the therapeutic codes: 96365 and 96366.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

UHC previously stated this policy could be expanded to include other drugs. As such, this issue is still very much a priority for the ISC, and the committee will continue to advocate against implementation, Dr. Phillips stresses.

The ACR’s position statement notes that all biologic drugs are complex and present risks of complications. To emphasize this reality and the risks associated with this policy, the ISC sent several letters to UnitedHealthcare and spoke to the insurance company’s leadership via conference call in October, sharing the detrimental effects this policy would have on rheumatologists’ ability to provide patients with access to these treatments.

Page: 1 2 3 | Single Page
Share: 

Filed under:American College of RheumatologyInsuranceLegislation & Advocacy Tagged with:ACR Insurance Subcommittee (ISC)downcodingmodifier 25United Healthcare (UHC)

Related Articles

    New Wins, Ongoing Challenges for ACR Insurance Subcommittee

    July 3, 2019

    Corrections to reimbursement system errors with Aetna and a Medicare contractor demonstrate the latest wins for all providers by the ACR’s Insurance Subcommittee. But the committee remains hard at work advocating for rheumatologists on several fronts.

    Bringing a Frontline Perspective to Insurance Advocacy

    March 21, 2019

    Early in his career as a resident at Washington University in St. Louis, Mo., Christopher Phillips, MD, felt a connection to his patients battling rheumatic diseases. Today, Dr. Phillips balances time with his solo private practice in Paducah, Ky., to help rheumatologists fight insurance battles for their patients in his role as chair of the…

    Coverage & Reimbursement Challenges: Updates from the ACR Insurance Subcommittee Chair

    February 7, 2020

    The ACR Insurance Subcommittee is working to address specialty pharmacy requirements for in-office treatments, elimination of consultation codes and other coverage and reimbursement challenges.

    Experts Discuss Current Insurance Issues Challenging Rheumatology

    March 12, 2020

    ATLANTA—From step therapy requirements to infusion center locations to evaluation and management coding, insurance issues bring frequent headaches to clinicians and patients. Experts discussed some of the most recent concerns in a session at the 2019 ACR/ARP Annual Meeting. Chris Phillips, MD, chair of the ACR’s Insurance Subcommittee (ISC), and Gary Bryant, MD, delegate to…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences